Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-09

Clinical Trial Update: Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing radiotherapy with concurrent gemcitabine and oxaliplatin in locally advanced, unresectable non-metastatic pancreatic adenocarci…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gemcitabine (Gemcitabine)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Locally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma | Phase 2 | Status: COMPLETED